Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Lawrence Otto Klein currently holds 925,580 shares of CRISPR Therapeutics AG (CRSP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lawrence Otto Klein has been a net seller of CRSP stock. They have purchased $0 and sold $26.1M worth of shares.
Lawrence Otto Klein's most recent insider trade was on Jun 15, 2026, when they sold 1,729 shares at $69.69 per share.
Lawrence Otto Klein serves as Executive at CRISPR Therapeutics AG (CRSP). They have executed 59 insider transactions totaling $26.1M over their tenure at the company.
Lawrence Otto Klein holds the position of Executive at CRISPR Therapeutics AG, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Lawrence Otto Klein has shown a selling trading pattern, with $0 in total purchases and $26.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Lawrence Otto Klein was on Mar 23, 2021, when they sold $11.3M worth of CRSP shares. This transaction involved 88,000 shares at $128.20 per share.
Lawrence Otto Klein currently owns 925,580 shares of CRISPR Therapeutics AG (CRSP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Lawrence Otto Klein's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Lawrence Otto Klein has 59 Form 4 filings on record as an insider at CRISPR Therapeutics AG.
Set alerts for Lawrence Otto Klein and 40,000+ other insiders.